Latest Content

EyeCon is an opportunity for ophthalmologists and optometrists to sit down together.

Roman-Lantzy, PhD, gives an urgent plea to eye care providers, whom she calls "the gatekeepers of the entire story" for pediatric patients with CVI.

Mary Beth Yackey, OD, outlines all that you need to know about the role of oculomics in eye care.

Catch up on the top stories in optometry during the week of September 14-September 18.

A comparison of ETDRS charts using Latin letters, Tumbling E, and Landolt C optotypes found the alternatives are comparable to letter acuity at the population level.

Vision testing results from 384 public transport drivers in Mumbai found the Visiolite 4K screener accurately matched standard assessments while cutting screening time by 65%.

In the latest episode of The Independent Advantage, Maria Sampalis, OD, gives a resounding "absolutely not" when posited with the question of whether or not eye care providers will be replaced by AI.

A recent study found that migraines were associated with higher adverse vision outcomes in a cohort of Norwegian adolescents.

Jem Martin, OD, discusses the accommodations and referrals any provider can offer, the red flags that should raise suspicion of CVI, and how the free TEACHCVI screening tool works in practice.

Optometrists should know what is expected, what is concerning, and when to contact the surgeon.

Catch up on the top stories in optometry during the week of September 7-September 11.

Startup S5G Therapeutics aims to move ubiquinol technology from the laboratory toward treatments for dry eye, Fuchs dystrophy, and other corneal conditions.

Mogenry (sonpiretigene isteparvovec, MC-010) is a gene therapy for retinitis pigmentosa with severe vision loss.